CellSeed Inc (7776):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CellSeed Inc (7776) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8067
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartilage sheet. It provides temperature-responsive cell cultureware for cell-sheet engineering, cell cutureware for cell collection and low cell binding cultureware. CellSeed’s UpCell finds application in tissue culture for regenerative medicine and for construction of 3D tissue. The company’s RepCell finds application in harvesting fragile cells such as stem cells and dendritic cells, and others. It also offers contract development and contract manufacturing services. The company has operations in Japan and Sweden. CellSeed is headquartered in Tokyo City, Japan.

CellSeed Inc (7776) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CellSeed Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CellSeed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CellSeed Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Xintela Enters into Collaboration Agreement with CellSeed 10
Licensing Agreements 11
Emmaus Medical Enters into Licensing Agreement with CellSeed 11
Equity Offering 12
CellSeed Completes IPO For US$39 Million 12
CellSeed Inc – Key Competitors 13
CellSeed Inc – Key Employees 14
CellSeed Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
CellSeed Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CellSeed Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CellSeed Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CellSeed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Xintela Enters into Collaboration Agreement with CellSeed 10
Emmaus Medical Enters into Licensing Agreement with CellSeed 11
CellSeed Completes IPO For US$39 Million 12
CellSeed Inc, Key Competitors 13
CellSeed Inc, Key Employees 14
CellSeed Inc, Subsidiaries 15

List of Figures
CellSeed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CellSeed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CellSeed Inc (7776):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Snowy Hydro Ltd-エネルギー分野:企業M&A・提携分析
    Summary Snowy Hydro Limited (Snowy Hydro) is an integrated energy utility that generates, supplies, trades, and retails electricity. The company produces power from gas and hydro sources. It owns and operates gas plants: Valley Power, Laverton North, and Colongra; and Snowy Mountains Scheme hydroele …
  • Teollisuuden Voima Oyj:企業の戦略的SWOT分析
    Teollisuuden Voima Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Rakuten Inc (4755):企業の財務・戦略的SWOT分析
    Rakuten Inc (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Calliditas Therapeutics AB-製薬・医療分野:企業M&A・提携分析
    Summary Calliditas Therapeutics AB (Calliditas), formerly, Pharmalink AB is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; a …
  • Mitie Group Plc (MTO):企業の財務・戦略的SWOT分析
    Mitie Group Plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company. It develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, and primary hyperoxalur …
  • Export Development Bank Of Egypt:企業の戦略・SWOT・財務情報
    Export Development Bank Of Egypt - Strategy, SWOT and Corporate Finance Report Summary Export Development Bank Of Egypt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Orsted AS:企業の発電所・SWOT分析2018
    Orsted AS - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • OMRON Corporation:企業の戦略・SWOT・財務分析
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AstraZeneca KK:製薬・医療:M&Aディール及び事業提携情報
    Summary AstraZeneca KK (AstraZeneca) a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic dise …
  • Swift Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Big Rivers Electric Corporation:発電所・企業SWOT分析
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Hogan Lovells International LLP:企業の戦略的SWOT分析
    Hogan Lovells International LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • University of Pennsylvania-医療機器分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). …
  • Globeimmune Inc (GBIM):企業の財務・戦略的SWOT分析
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • AMTEC Corporation:企業の戦略・SWOT・財務情報
    AMTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary AMTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China North Industries Group Corp:企業の戦略的SWOT分析
    China North Industries Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Global Investment House KPSC:企業の戦略的SWOT分析
    Global Investment House KPSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Pharnext SA (ALPHA):企業の財務・戦略的SWOT分析
    Summary Pharnext SA (Pharnext), formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases. The company offers pleotherapy, a proprietary research and development platform based on network pharmacology that uses wide genomic data to ident …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆